255 related articles for article (PubMed ID: 28830209)
1. Puerarin Improves Vascular Insulin Resistance and Cardiovascular Remodeling in Salt-Sensitive Hypertension.
Tan C; Wang A; Liu C; Li Y; Shi Y; Zhou MS
Am J Chin Med; 2017; 45(6):1169-1184. PubMed ID: 28830209
[TBL] [Abstract][Full Text] [Related]
2. Puerarin Reduces Blood Pressure in Spontaneously Hypertensive Rats by Targeting eNOS.
Shi W; Yuan R; Chen X; Xin Q; Wang Y; Shang X; Cong W; Chen K
Am J Chin Med; 2019; 47(1):19-38. PubMed ID: 30612457
[TBL] [Abstract][Full Text] [Related]
3. Macrophage Depletion Improves Endothelial Insulin Resistance and Protects against Cardiovascular Injury in Salt-Sensitive Hypertension.
Liu YY; Luo J; Cai R; Zhang J; Xu Q; Tian Y; Zhou MS
Biomed Res Int; 2020; 2020():5073762. PubMed ID: 32851077
[TBL] [Abstract][Full Text] [Related]
4. Puerarin protects against endothelial dysfunction and end-organ damage in Ang II-induced hypertension.
Li X; Lin Y; Zhou H; Li Y; Wang A; Wang H; Zhou MS
Clin Exp Hypertens; 2017; 39(1):58-64. PubMed ID: 28060542
[TBL] [Abstract][Full Text] [Related]
5. Vascular inflammation, insulin resistance, and endothelial dysfunction in salt-sensitive hypertension: role of nuclear factor kappa B activation.
Zhou MS; Schulman IH; Raij L
J Hypertens; 2010 Mar; 28(3):527-35. PubMed ID: 19898250
[TBL] [Abstract][Full Text] [Related]
6. Dietary iron restriction prevents hypertensive cardiovascular remodeling in Dahl salt-sensitive rats.
Naito Y; Hirotani S; Sawada H; Akahori H; Tsujino T; Masuyama T
Hypertension; 2011 Mar; 57(3):497-504. PubMed ID: 21263124
[TBL] [Abstract][Full Text] [Related]
7. Endothelial dysfunction and cardiorenal injury in experimental salt-sensitive hypertension: effects of antihypertensive therapy.
Hayakawa H; Coffee K; Raij L
Circulation; 1997 Oct; 96(7):2407-13. PubMed ID: 9337217
[TBL] [Abstract][Full Text] [Related]
8. Effects of Xin-Ji-Er-Kang formula on 2K1C-induced hypertension and cardiovascular remodeling in rats.
Guo K; Lan CZ; Yu TT; Huang LL; Wang XH; Pan C; Gao S
J Ethnopharmacol; 2014 Sep; 155(2):1227-35. PubMed ID: 25063306
[TBL] [Abstract][Full Text] [Related]
9. Combination therapy of amlodipine and atorvastatin has more beneficial vascular effects than monotherapy in salt-sensitive hypertension.
Zhou MS; Tian R; Jaimes EA; Raij L
Am J Hypertens; 2014 Jun; 27(6):873-80. PubMed ID: 24413709
[TBL] [Abstract][Full Text] [Related]
10. Dietary salt restriction improves cardiac and adipose tissue pathology independently of obesity in a rat model of metabolic syndrome.
Hattori T; Murase T; Takatsu M; Nagasawa K; Matsuura N; Watanabe S; Murohara T; Nagata K
J Am Heart Assoc; 2014 Dec; 3(6):e001312. PubMed ID: 25468654
[TBL] [Abstract][Full Text] [Related]
11. In salt-sensitive hypertension, increased superoxide production is linked to functional upregulation of angiotensin II.
Zhou MS; Adam AG; Jaimes EA; Raij L
Hypertension; 2003 Nov; 42(5):945-51. PubMed ID: 12975388
[TBL] [Abstract][Full Text] [Related]
12. Rosuvastatin attenuates hypertension-induced cardiovascular remodeling without affecting blood pressure in DOCA-salt hypertensive rats.
Loch D; Levick S; Hoey A; Brown L
J Cardiovasc Pharmacol; 2006 Mar; 47(3):396-404. PubMed ID: 16633082
[TBL] [Abstract][Full Text] [Related]
13. Puerarin attenuates pressure overload-induced cardiac hypertrophy.
Yuan Y; Zong J; Zhou H; Bian ZY; Deng W; Dai J; Gan HW; Yang Z; Li H; Tang QZ
J Cardiol; 2014 Jan; 63(1):73-81. PubMed ID: 23906530
[TBL] [Abstract][Full Text] [Related]
14. Puerarin attenuates endothelial insulin resistance through inhibition of inflammatory response in an IKKβ/IRS-1-dependent manner.
Huang F; Liu K; Du H; Kou J; Liu B
Biochimie; 2012 May; 94(5):1143-50. PubMed ID: 22314193
[TBL] [Abstract][Full Text] [Related]
15. Management of Diabetes Mellitus with Puerarin, a Natural Isoflavone From Pueraria lobata.
Chen X; Yu J; Shi J
Am J Chin Med; 2018; 46(8):1771-1789. PubMed ID: 30525896
[TBL] [Abstract][Full Text] [Related]
16. The anti-hypertensive effect of Danshen (Salvia miltiorrhiza) and Gegen (Pueraria lobata) formula in rats and its underlying mechanisms of vasorelaxation.
Ng CF; Koon CM; Cheung DW; Lam MY; Leung PC; Lau CB; Fung KP
J Ethnopharmacol; 2011 Oct; 137(3):1366-72. PubMed ID: 21855622
[TBL] [Abstract][Full Text] [Related]
17. Protective effect of Xin-Ji-Er-Kang on cardiovascular remodeling in high-salt induced hypertensive mice: Role ofoxidative stress and endothelial dysfunction.
Wang XY; Huang GY; Lian FZ; Pan M; Ruan CS; Ling XX; Chen ML; Shen AZ; Gao S
Biomed Pharmacother; 2019 Jul; 115():108937. PubMed ID: 31078040
[TBL] [Abstract][Full Text] [Related]
18. Asiatic acid alleviates cardiovascular remodelling in rats with L-NAME-induced hypertension.
Bunbupha S; Prachaney P; Kukongviriyapan U; Kukongviriyapan V; Welbat JU; Pakdeechote P
Clin Exp Pharmacol Physiol; 2015 Nov; 42(11):1189-97. PubMed ID: 26234646
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive effect of glucagon-like peptide 1 in Dahl salt-sensitive rats.
Yu M; Moreno C; Hoagland KM; Dahly A; Ditter K; Mistry M; Roman RJ
J Hypertens; 2003 Jun; 21(6):1125-35. PubMed ID: 12777949
[TBL] [Abstract][Full Text] [Related]
20. DPP-4 inhibitor linagliptin ameliorates cardiovascular injury in salt-sensitive hypertensive rats independently of blood glucose and blood pressure.
Koibuchi N; Hasegawa Y; Katayama T; Toyama K; Uekawa K; Sueta D; Kusaka H; Ma M; Nakagawa T; Lin B; Kim-Mitsuyama S
Cardiovasc Diabetol; 2014 Nov; 13():157. PubMed ID: 25471116
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
